GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
T

Tong Ren Tang Technologies Co 1666.HK · HKD

Health Care · HKEX · 🇭🇰 Hong Kong

Compare

2.94

-1.01%

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥7.56bn

FY2016FY2025

Net income

CN¥462.2m

FY2016FY2025

Free cash flow

CN¥1.69bn

FY2016FY2025

Shareholders' equity

CN¥8.57bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueCN¥7.56bnCN¥8.47bnCN¥7.90bnCN¥6.99bnCN¥6.30bnCN¥5.37bnCN¥5.22bnCN¥5.90bnCN¥5.86bnCN¥5.44bn
Gross profitCN¥2.88bnCN¥3.36bnCN¥3.32bnCN¥3.02bnCN¥2.67bnCN¥2.41bnCN¥2.40bnCN¥2.83bnCN¥2.95bnCN¥2.76bn
Research and developmentCN¥96.5mCN¥98.9mCN¥137.1mCN¥91.5mCN¥57.0mCN¥76.5mCN¥33.0mCN¥32.5mCN¥32.2mCN¥27.0m
Operating incomeCN¥935.7mCN¥1.15bnCN¥1.30bnCN¥1.42bnCN¥1.26bnCN¥1.10bnCN¥1.09bnCN¥1.40bnCN¥1.36bnCN¥1.17bn
Net incomeCN¥462.2mCN¥608.7mCN¥688.4mCN¥679.9mCN¥591.7mCN¥545.4mCN¥487.2mCN¥790.7mCN¥777.6mCN¥694.8m
Diluted earnings per share0.360.480.540.530.460.430.380.620.610.54

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsCN¥16.00bnCN¥16.81bnCN¥15.76bnCN¥14.56bnCN¥13.52bnCN¥12.76bnCN¥12.21bnCN¥11.40bnCN¥10.35bnCN¥9.55bn
Cash and short-term investmentsCN¥5.64bnCN¥5.11bnCN¥4.94bnCN¥4.88bnCN¥4.53bnCN¥4.07bnCN¥4.59bnCN¥4.29bnCN¥3.58bnCN¥3.72bn
Total liabilitiesCN¥3.89bnCN¥4.95bnCN¥4.50bnCN¥4.05bnCN¥4.01bnCN¥3.72bnCN¥3.56bnCN¥2.91bnCN¥2.82bnCN¥2.68bn
DebtCN¥2.34bnCN¥2.43bnCN¥1.63bnCN¥1.59bnCN¥1.64bnCN¥1.69bnCN¥1.46bnCN¥1.11bnCN¥1.13bnCN¥1.13bn
Shareholders' equityCN¥8.57bnCN¥8.41bnCN¥8.04bnCN¥7.56bnCN¥6.97bnCN¥6.69bnCN¥6.45bnCN¥6.20bnCN¥5.62bnCN¥5.14bn
Shares outstanding1,281m1,281m1,281m1,281m1,281m1,281m1,281m1,281m1,281m1,281m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsCN¥1.82bnCN¥18.2mCN¥646.4mCN¥844.3mCN¥1.21bnCN¥508.4mCN¥1.23bnCN¥1.15bnCN¥793.0mCN¥478.3m
Capital spending−CN¥136.3m−CN¥203.2m−CN¥120.6m−CN¥184.2m−CN¥182.4m−CN¥636.8m−CN¥245.5m−CN¥416.2m−CN¥480.1m−CN¥506.4m
Free cash flowCN¥1.69bn−CN¥185.0mCN¥525.8mCN¥660.1mCN¥1.02bn−CN¥128.4mCN¥981.4mCN¥733.1mCN¥312.9m−CN¥28.1m
Dividends paid−CN¥266.3m−CN¥266.3m−CN¥236.7m−CN¥239.0m−CN¥239.0m−CN¥239.0m−CN¥268.9m−CN¥254.0m−CN¥239.0m−CN¥224.1m

Latest quarters

By quarter end

Jun 2026Dec 2025Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022
RevenueCN¥3.48bnCN¥3.20bnCN¥4.36bnCN¥3.74bnCN¥4.72bnCN¥3.30bnCN¥4.60bnCN¥3.47bn
Gross profitCN¥1.25bnCN¥1.21bnCN¥1.66bnCN¥1.56bnCN¥1.79bnCN¥1.49bnCN¥1.83bnCN¥1.51bn
Operating incomeCN¥493.6mCN¥271.0mCN¥664.6mCN¥411.9mCN¥737.3mCN¥554.8mCN¥747.3mCN¥761.7m
Net incomeCN¥286.6mCN¥67.2mCN¥395.0mCN¥108.5mCN¥500.1mCN¥259.0mCN¥429.4mCN¥308.6m
Diluted earnings per share0.220.050.310.080.390.200.340.24
Cash from operationsCN¥914.0mCN¥539.0mCN¥1.31bnCN¥546.0m−CN¥528.0m−CN¥323.0mCN¥1.08bnCN¥200.0m
Capital spending−CN¥35.0m−CN¥72.0m−CN¥63.0m−CN¥107.0m−CN¥96.0m−CN¥43.0m−CN¥80.0m−CN¥114.0m
Free cash flowCN¥879.0mCN¥467.0mCN¥1.24bnCN¥439.0m−CN¥624.0m−CN¥366.0mCN¥996.0mCN¥86.0m
Total assetsCN¥15.57bnCN¥16.00bnCN¥16.96bnCN¥16.81bnCN¥16.67bnCN¥15.76bnCN¥15.26bnCN¥14.56bn
Cash and short-term investmentsCN¥5.84bnCN¥5.64bnCN¥6.00bnCN¥5.11bnCN¥5.09bnCN¥4.94bnCN¥5.77bnCN¥4.88bn
DebtCN¥831.8mCN¥2.34bnCN¥2.82bnCN¥2.83bnCN¥2.81bnCN¥1.90bnCN¥1.93bnCN¥1.86bn
Shareholders' equityCN¥8.52bnCN¥8.57bnCN¥8.51bnCN¥8.41bnCN¥8.28bnCN¥8.04bnCN¥7.81bnCN¥7.56bn

Financial ratios

Data as of 16 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin38.0%39.6%42.0%43.3%42.4%44.9%
Operating margin12.4%13.6%16.5%20.2%20.0%20.5%
Net margin6.1%7.2%8.7%9.7%9.4%10.1%
Return on equity5.4%7.2%8.6%9.0%8.5%8.2%
Return on assets2.9%3.6%4.4%4.7%4.4%4.3%
Free cash flow yield42.2%4.8%16.5%22.2%29.9%24.7%
Revenue growth-10.7%7.2%13.0%11.0%17.2%2.9%
Earnings growth-24.1%-11.6%1.3%14.9%8.5%11.9%
Current ratio5.72x3.81x4.49x4.42x3.31x3.04x
Debt to equity0.26x0.33x0.22x0.23x0.26x0.27x
Equity ratio53.5%50.0%51.0%51.9%51.6%52.4%
Interest coverage13.58x15.28x24.78x22.55x17.47x18.30x
R&D as a share of sales1.3%1.2%1.7%1.3%0.9%1.4%
Buybacks as a share of market value0.0%0.0%0.0%0.0%0.0%0.0%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue2.7%7.1%4.8%
Operating income-12.9%-3.2%-0.9%
Net income-12.1%-3.3%-3.1%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin38.9%40.7%41.5%44.4%
Operating margin13.0%15.5%16.8%18.9%
Net margin6.7%7.9%8.4%10.0%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings11.010.311.19.716.611.420.116.618.626.5
Price to sales0.70.71.00.91.61.21.92.22.53.4

Dividends and splits

Per share, in the currency the company pays

Paid for 25 years. Last went ex-dividend on 16 Jun 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year0.2070.1970.2280.1760.1870.1940.1750.205
  • 2-for-1 split · 17 Jun 2014
  • 3-for-1 split · 11 Apr 2011

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.